These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35485166)

  • 1. Probiotic peanut oral immunotherapy is associated with long-term persistence of 8-week sustained unresponsiveness and long-lasting quality-of-life improvement.
    Loke P; Hsiao KC; Lozinsky AC; Ashley SE; Lloyd M; Pitkin S; Axelrad CJ; Jayawardana KS; Tey D; Su EL; Robinson M; Leung ASY; Dunn Galvin A; Tang MLK
    Clin Exp Allergy; 2022 Jun; 52(6):806-811. PubMed ID: 35485166
    [No Abstract]   [Full Text] [Related]  

  • 2. Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial.
    Loke P; Orsini F; Lozinsky AC; Gold M; O'Sullivan MD; Quinn P; Lloyd M; Ashley SE; Pitkin S; Axelrad C; Metcalfe JR; Su EL; Tey D; Robinson MN; Allen KJ; Prescott SL; Galvin AD; Tang MLK;
    Lancet Child Adolesc Health; 2022 Mar; 6(3):171-184. PubMed ID: 35123664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of a probiotic with peanut oral immunotherapy: A randomized trial.
    Tang ML; Ponsonby AL; Orsini F; Tey D; Robinson M; Su EL; Licciardi P; Burks W; Donath S
    J Allergy Clin Immunol; 2015 Mar; 135(3):737-44.e8. PubMed ID: 25592987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term benefit of probiotic peanut oral immunotherapy on quality of life in a randomized trial.
    Dunn Galvin A; Lloyd M; Hsiao KC; Tang MLK;
    J Allergy Clin Immunol Pract; 2021 Dec; 9(12):4493-4495.e1. PubMed ID: 34389505
    [No Abstract]   [Full Text] [Related]  

  • 5. Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study).
    Chebar Lozinsky A; Loke P; Orsini F; O'Sullivan M; L Prescott S; Gold MS; Quinn P; DunnGalvin A; Lk Tang M;
    BMJ Open; 2020 Sep; 10(9):e035871. PubMed ID: 32912942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral immunotherapy for treatment of peanut allergy.
    Dunlop JH
    J Investig Med; 2020 Aug; 68(6):1152-1155. PubMed ID: 32665367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol of a phase 2, dual-centre, randomised, controlled trial evaluating the effectiveness of probiotic and egg oral immunotherapy at inducing desensitisation or sustained unresponsiveness (remission) in participants with egg allergy compared with placebo (Probiotic Egg Allergen Oral Immunotherapy for Treatment of Egg Allergy: PEAT study).
    Loke P; Chebar Lozinsky A; Orsini F; Wong LS; Leung AS; Tham EH; Lopata AL; Shek LP; Tang ML;
    BMJ Open; 2021 Jul; 11(7):e044331. PubMed ID: 34233966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peanut Oral Immunotherapy: State of the Art.
    Tang MLK; Lozinsky AC; Loke P
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):97-110. PubMed ID: 31761124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for sustained desensitization after sublingual peanut immunotherapy.
    Bohle B
    J Allergy Clin Immunol; 2023 Jun; 151(6):1477-1478. PubMed ID: 37086923
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term follow-up of children who achieved sustained unresponsiveness after peanut oral immunotherapy.
    Lee ASE; Baker MG; Cox AL; Oriel RC; Tsuang A; Sicherer SH; Kattan JD
    J Allergy Clin Immunol Pract; 2024 Jan; 12(1):255-256. PubMed ID: 37852440
    [No Abstract]   [Full Text] [Related]  

  • 11. Peanut allergy and oral immunotherapy.
    Lee TH; Chan JKC; Lau PC; Luk WP; Fung LH
    Hong Kong Med J; 2019 Jun; 25(3):228-234. PubMed ID: 31178442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified peanut oral immunotherapy protocol safely and effectively induces desensitization.
    Bird JA; Feldman M; Arneson A; Dougherty I; Brown LS; Burk CM; Kulis M; Burks W; Gill M
    J Allergy Clin Immunol Pract; 2015; 3(3):433-5.e1-3. PubMed ID: 25609341
    [No Abstract]   [Full Text] [Related]  

  • 13. Remission of peanut allergy is associated with rewiring of allergen-driven T helper 2-related gene networks.
    Ashley SE; Jones AC; Anderson D; Holt PG; Bosco A; Tang MLK
    Allergy; 2022 Oct; 77(10):3015-3027. PubMed ID: 35615783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Immunotherapy for Peanut Allergy.
    Anagnostou K; Clark A
    Annu Rev Med; 2016; 67():375-85. PubMed ID: 26332004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose immunotherapy in very young children to treat peanut allergy.
    Vickery BP
    Expert Rev Clin Immunol; 2016 Dec; 12(12):1251-1253. PubMed ID: 27599211
    [No Abstract]   [Full Text] [Related]  

  • 16. Peanut Oral Immunotherapy: a Current Perspective.
    Patrawala M; Shih J; Lee G; Vickery B
    Curr Allergy Asthma Rep; 2020 Apr; 20(5):14. PubMed ID: 32314071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open-label follow-on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy.
    Fernandez-Rivas M; Vereda A; Vickery BP; Sharma V; Nilsson C; Muraro A; Hourihane JO; DunnGalvin A; du Toit G; Blumchen K; Beyer K; Smith A; Ryan R; Adelman DC; Jones SM
    Allergy; 2022 Mar; 77(3):991-1003. PubMed ID: 34320250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Trend in Immunotherapy for Peanut Allergy.
    Joo Chan C; Richardo T; Lim RLH
    Int Rev Immunol; 2018; 37(6):279-290. PubMed ID: 30638084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained unresponsiveness to peanut after long-term peanut epicutaneous immunotherapy.
    Brown-Whitehorn TF; de Blay F; Spergel JM; Green TD; Peillon A; Sampson HA; Campbell DE
    J Allergy Clin Immunol Pract; 2021 Jan; 9(1):524-526. PubMed ID: 32835872
    [No Abstract]   [Full Text] [Related]  

  • 20. Current opinion and review on peanut oral immunotherapy.
    Deol S; Bird JA
    Hum Vaccin Immunother; 2014; 10(10):3017-21. PubMed ID: 25483680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.